Full Report
New research from RunSafe Security highlights growing operational and clinical impact of cyber threats targeting connected healthcare technology.... The post RunSafe Index reports that healthcare cybersecurity gaps are widening faster than existing defenses can close them appeared first on Industrial Cyber.
Analysis Summary
# Industry News: Medical Device Cybersecurity Gaps Widen as Procurement Standards Tighten
## Summary
The 2026 RunSafe Medical Device Cybersecurity Index reveals a critical disconnect where cyber threats to connected healthcare technology are outpacing defensive capabilities, with 80% of device-related incidents now resulting in direct disruptions to patient care. Despite these widening gaps, healthcare providers are aggressively institutionalizing security, with 84% now including cybersecurity mandates in RFPs and a majority rejecting devices that fail to meet security benchmarks.
## Key Details
- **Date:** April 30, 2026
- **Companies Involved:** RunSafe Security (Primary Research Issuer)
- **Category:** Market Analysis / Research Report
## The Story
The "2026 Medical Device Cybersecurity Index" by RunSafe Security depicts a healthcare sector at a crossroads. While the adoption of AI-enabled medical devices and cloud-connected clinical tools is accelerating, these innovations are introducing systemic vulnerabilities that existing legacy defenses cannot mitigate. Currently, 24% of healthcare organizations report their medical devices have been impacted by cyber incidents, shifting the narrative from data privacy to physical patient safety.
In response, the industry is seeing a massive shift in procurement behavior. Security is no longer an "afterthought" but a "gatekeeper" in the purchasing process. The report highlights a jump in Software Bill of Materials (SBOM) importance, with 35% of buyers stating they will refuse to consider any device lacking one. Furthermore, there is a surge in "runtime protection" technology, as organizations seek ways to shield vulnerable legacy equipment that cannot be easily patched or replaced.
## Business Impact
### For the Companies Involved (RunSafe Security)
- Reinforces RunSafe’s position as a thought leader in "runtime protection," a niche that is seeing high demand (82% of organizations are now piloting or deploying such tools).
### For Competitors (Medical Device Manufacturers)
- **Non-compliance is now a revenue risk:** Manufacturers who fail to provide SBOMs or meet FDA/EU MDR standards face immediate disqualification from over half of the market (56%).
- **Market Differentiation:** Security features are no longer "premium" add-ons but essential requirements to maintain market share.
### For Customers (Healthcare Providers)
- **Higher Costs:** 76% of organizations represent a willingness to pay a premium for secured devices, acknowledging that the cost of an incident outweighs the upfront purchase price.
- **Operational Hurdle:** Procurement cycles may lengthen as more rigorous testing and documentation (SBOMs, risk assessments) are required.
### For the Market
- **Standardization:** The industry is converging toward a "Security-by-Design" mandate, driven by both regulatory pressure (FDA/EU MDR) and buyer demand.
- **Investment Shift:** Funding is moving away from traditional perimeter IT security toward OT (Operational Technology) and device-level protection.
## Technical Implications
- **SBOM Maturity:** The Software Bill of Materials is becoming the standard for vulnerability management.
- **Legacy Vulnerability:** The continued reliance on "unsupported" systems remains the primary technical debt.
- **Runtime Protection:** A shift toward "adaptive defense mechanisms" that monitor code execution in real-time is emerging as the primary solution for devices that cannot be frequently rebooted for patching.
## Strategic Analysis
- **Market Positioning:** Healthcare organizations are transitioning from "reactive" (detection) to "proactive" (procurement-led security).
- **Competitive Advantage:** Device manufacturers who can demonstrate "transparency" (through SBOMs) and "resilience" (through runtime protection) will dominate the 2026-2027 buying cycle.
- **Challenges:** The speed of AI integration in medical devices is currently outrunning the development of AI-specific security frameworks.
## Industry Reactions
- **RunSafe CEO Joseph M. Saunders:** Emphasizes that cybersecurity has moved beyond a technical concern to a "regulatory and patient safety imperative."
- **Market Response:** The nearly 100% increase in organizations including security in RFPs (from 38% in 2025 to 84% in 2026) suggests a massive, industry-wide professionalization of security procurement.
## Future Outlook
- **Regulatory Hardening:** Expect the FDA and EU MDR to introduce even stricter clinical safety requirements tied specifically to software integrity.
- **AI Risks:** Watch for a new wave of "adversarial AI" targeting diagnostic devices, necessitating a new category of "AI-shielding" security tools.
- **Insurance Impact:** Cyber insurance premiums for hospitals will likely become tiered based on the percentage of their device fleet protected by runtime tools and SBOM documentation.
## For Security Professionals
Practitioners should focus on integrating security into the clinical supply chain. If your organization is not currently demanding SBOMs for every new connected device, you are falling behind the 81% of your peers who consider them essential. There is also a clear shift toward "runtime protection" as a necessary layer for legacy medical equipment that persists in clinical environments past its end-of-life.